Intraperitoneal radioimmunotherapy: Auger electron emitters for solid tumors

Research output: Contribution to journalComment/debate

6 Citations (Scopus)

Abstract

Evaluation of: Boudousq V, Ricaud S, Garambois V et al.: Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. J. Nucl. Med. 51, 1748-1755 (2010). Mesothelioma, pseudomyxoma peritonei, ovarian and colon cancers, and several other malignancies produce peritoneal carcinomatosis in their advanced stages. This condition is typically managed with curative intention by means of a radical cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. The method has been shown to improve the survival of some patients with peritoneal dissemination. However, the intracavitary instillation of chemotherapy results in a nonuniform drug distribution and allows penetration of the drug only into the outermost layer of the cancer nodule. Authors of the current study demonstrate that 125I-radiolabeled monoclonal antibody, 35A7, which recognizes anti-carcinoembryonic antigen, can be used effectively and safely with low toxicity in the therapy of small volume peritoneal carcinomatosis after cytoreductive surgery.

Original languageEnglish (US)
Pages (from-to)491-494
Number of pages4
JournalImmunotherapy
Volume3
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Radioimmunotherapy
Electrons
Carcinoma
Monoclonal Antibodies
Pseudomyxoma Peritonei
Drug Therapy
Neoplasms
Carcinoembryonic Antigen
Mesothelioma
Pharmaceutical Preparations
Ovarian Neoplasms
Colonic Neoplasms
Survival
Therapeutics

Keywords

  • Auger electron
  • anti-CEA 35A7
  • iodine-125
  • peritoneal carcinomatosis
  • radioimmunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this

Intraperitoneal radioimmunotherapy : Auger electron emitters for solid tumors. / Baranowska-Kortylewicz, Janina.

In: Immunotherapy, Vol. 3, No. 4, 01.04.2011, p. 491-494.

Research output: Contribution to journalComment/debate

@article{e9ff6f1cfa0d49c5b247a6c9da5b38a5,
title = "Intraperitoneal radioimmunotherapy: Auger electron emitters for solid tumors",
abstract = "Evaluation of: Boudousq V, Ricaud S, Garambois V et al.: Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. J. Nucl. Med. 51, 1748-1755 (2010). Mesothelioma, pseudomyxoma peritonei, ovarian and colon cancers, and several other malignancies produce peritoneal carcinomatosis in their advanced stages. This condition is typically managed with curative intention by means of a radical cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. The method has been shown to improve the survival of some patients with peritoneal dissemination. However, the intracavitary instillation of chemotherapy results in a nonuniform drug distribution and allows penetration of the drug only into the outermost layer of the cancer nodule. Authors of the current study demonstrate that 125I-radiolabeled monoclonal antibody, 35A7, which recognizes anti-carcinoembryonic antigen, can be used effectively and safely with low toxicity in the therapy of small volume peritoneal carcinomatosis after cytoreductive surgery.",
keywords = "Auger electron, anti-CEA 35A7, iodine-125, peritoneal carcinomatosis, radioimmunotherapy",
author = "Janina Baranowska-Kortylewicz",
year = "2011",
month = "4",
day = "1",
doi = "10.2217/imt.11.11",
language = "English (US)",
volume = "3",
pages = "491--494",
journal = "Immunotherapy",
issn = "1750-743X",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Intraperitoneal radioimmunotherapy

T2 - Auger electron emitters for solid tumors

AU - Baranowska-Kortylewicz, Janina

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Evaluation of: Boudousq V, Ricaud S, Garambois V et al.: Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. J. Nucl. Med. 51, 1748-1755 (2010). Mesothelioma, pseudomyxoma peritonei, ovarian and colon cancers, and several other malignancies produce peritoneal carcinomatosis in their advanced stages. This condition is typically managed with curative intention by means of a radical cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. The method has been shown to improve the survival of some patients with peritoneal dissemination. However, the intracavitary instillation of chemotherapy results in a nonuniform drug distribution and allows penetration of the drug only into the outermost layer of the cancer nodule. Authors of the current study demonstrate that 125I-radiolabeled monoclonal antibody, 35A7, which recognizes anti-carcinoembryonic antigen, can be used effectively and safely with low toxicity in the therapy of small volume peritoneal carcinomatosis after cytoreductive surgery.

AB - Evaluation of: Boudousq V, Ricaud S, Garambois V et al.: Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. J. Nucl. Med. 51, 1748-1755 (2010). Mesothelioma, pseudomyxoma peritonei, ovarian and colon cancers, and several other malignancies produce peritoneal carcinomatosis in their advanced stages. This condition is typically managed with curative intention by means of a radical cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. The method has been shown to improve the survival of some patients with peritoneal dissemination. However, the intracavitary instillation of chemotherapy results in a nonuniform drug distribution and allows penetration of the drug only into the outermost layer of the cancer nodule. Authors of the current study demonstrate that 125I-radiolabeled monoclonal antibody, 35A7, which recognizes anti-carcinoembryonic antigen, can be used effectively and safely with low toxicity in the therapy of small volume peritoneal carcinomatosis after cytoreductive surgery.

KW - Auger electron

KW - anti-CEA 35A7

KW - iodine-125

KW - peritoneal carcinomatosis

KW - radioimmunotherapy

UR - http://www.scopus.com/inward/record.url?scp=79953830567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953830567&partnerID=8YFLogxK

U2 - 10.2217/imt.11.11

DO - 10.2217/imt.11.11

M3 - Comment/debate

C2 - 21463190

AN - SCOPUS:79953830567

VL - 3

SP - 491

EP - 494

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 4

ER -